Results 41 to 50 of about 1,115 (179)

The Relationship of Partial Pressure of Carbon Dioxide (PaCO2) with Disease Severity Indicators Such as BODE and GOLD in Hospitalized COPD Patients

open access: yesInternational Journal of Clinical Practice, Volume 2022, Issue 1, 2022., 2022
Purpose. This study aimed to investigate the relationship of partial pressure of carbon dioxide (PaCO2) with BODE and GOLD in stable COPD subjects and to explore the predictive value of PaCO2 for severe COPD (BODE index score ≥5 or GOLD index score ≥3). Patients and Methods.
Xiaodiao Zhang   +14 more
wiley   +1 more source

Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis

open access: yesEuropean Respiratory Review, 2022
Purpose: To assess the safety and efficacy of extracorporeal carbon dioxide removal (ECCO2R) versus standard care in patients with acute hypoxaemic respiratory failure (AHRF). Methods: MEDLINE, Embase and clinical trial registries were searched from 1994
Jonathan E. Millar   +7 more
doaj   +1 more source

Ultraprotective ventilation allowed by extracorporeal CO2 removal improves the right ventricular function in acute respiratory distress syndrome patients: a quasi-experimental pilot study

open access: yesAnnals of Intensive Care, 2021
Background Right ventricular (RV) failure is a common complication in moderate-to-severe acute respiratory distress syndrome (ARDS). RV failure is exacerbated by hypercapnic acidosis and overdistension induced by mechanical ventilation.
Suzanne Goursaud   +4 more
doaj   +1 more source

ECCO2R, a french national survey [PDF]

open access: yesIntensive Care Medicine Experimental, 2015
ECCO2R (extracorporeal dioxide carbon removal) is an extracorporeal decarboxylation technology described in 19781. Physiological studies showed that 50% of produced CO2 were eliminated2. Potential indications are: ultra-protective mechanical ventilation (MV) for acute respiratory distress syndrome (ARDS)3 and hypercapnic patients at risk of failure of ...
Deniau, B   +4 more
openaire   +1 more source

Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study

open access: yes, 2021
Background/aim: Treatment of severe hypercapnic respiratory failure (HRF) has some challenges in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS), especially when lung protective ventilation (LPV ...
Inal, Volkan   +3 more
core   +1 more source

Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome

open access: yesFrontiers in Medicine, 2020
Coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) is associated with high mortality. Lung-protective ventilation is the current standard of care in patients with ARDS, but it might lead to hypercapnia, which is ...
Faeq Husain-Syed   +36 more
doaj   +1 more source

The use of extracorporeal CO2 removal in acute respiratory failure

open access: yesAnnals of Intensive Care, 2021
Background Chronic obstructive pulmonary disease (COPD) exacerbation and protective mechanical ventilation of acute respiratory distress syndrome (ARDS) patients induce hypercapnic respiratory acidosis.
Raphaël Giraud   +5 more
doaj   +1 more source

Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol [PDF]

open access: yes, 2016
BackgroundThe extracorporeal membrane carbon dioxide removal (ECCO2R) system is primarily designed for the purpose of removing CO2 from the body for patients with potentially reversible severe acute hypercapnic respiratory failure or being considered for
Sue Bayliss   +9 more
core   +2 more sources

Control of respiratory drive by extracorporeal CO2 removal in acute exacerbation of COPD breathing on non-invasive NAVA

open access: yesCritical Care, 2019
Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) and non-invasive neurally adjusted ventilator assist (NIV-NAVA) are two promising techniques which may prevent complications related to prolonged invasive mechanical ventilation in patients ...
Christian Karagiannidis   +7 more
doaj   +1 more source

Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCO<sub>2</sub>R) in acute respiratory failure patients. [PDF]

open access: yesCrit Care
International audienceBackground : Ultra-protective ventilation is the combination of low airway pressures and tidal volume (Vt) combined with extra corporeal carbon dioxide removal (ECCO2R).
Monet C   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy